CLINICAL_TRIALS
trial_result
· 2022-10-06
Clinical Trial Update: Efficacy of Suvorexant to Treat Insomnia Related to Bipolar Disorder [Phase 4]
Summary
A Phase 4 study evaluated the efficacy of suvorexant for insomnia associated with bipolar disorder; results have been posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Stanford University | Conditions: Insomnia, Bipolar Disorder | Phase 4 | Status: COMPLETED | Results posted: 2022-10-06